Skip to main content
. 2018 Mar 8;144(4):349–359. doi: 10.1001/jamaoto.2017.3406

Table 1. Baseline Characteristics of Patients According to the Duration of Time From Surgery to Radiation (TS-RT).

Characteristic TS-RT
No. (%) % (95% CI)
≤42 d 43-49 d ≥50 d Difference Between 43-49 d and ≤42 d Difference Between ≥50 d and ≤42 d
Sex
Male 7585 (78) 3537 (75) 7846 (73) −3.0 (−4.5 to −1.5) −4.5 (−5.6 to −3.3)
Female 2180 (22) 1198 (25) 2870 (27) 3.0 (1.5 to 4.5) 4.5 (3.3 to 5.6)
Age, y
≤50 2389 (24) 972 (21) 2186 (20) −3.9 (−5.4 to −2.5) −4.1 (−5.2 to −2.9)
51-60 3628 (37) 1746 (37) 3793 (35) −0.3 (−2.0 to 1.4) −1.8 (−3.1 to −0.4)
61-70 2544 (26) 1320 (28) 2959 (28) 1.8 (0.3 to 3.4) 1.6 (0.3 to 2.8)
≥71 1204 (12) 697 (15) 1778 (17) 2.4 (1.2 to 3.6) 4.3 (3.3 to 5.2)
Race
White 8788 (90) 4147 (88) 9239 (86) −2.4 (−3.5 to −1.3) −3.8 (−4.7 to −2.9)
Black 657 (7) 405 (9) 1079 (10) 1.8 (0.9 to 2.8) 3.3 (2.6 to 4.1)
Other 320 (3) 183 (4) 398 (4) 0.6 (−0.1 to 1.2) 0.4 (−0.1 to 0.9)
Educationa
≥21% 1365 (14) 744 (16) 2005 (19) 1.7 (0.5 to 3.0) 4.7 (3.7 to 5.7)
13%-20.9% 2534 (26) 1231 (26) 2961 (28) 0.1 (−1.5 to 1.6) 1.7 (0.5 to 2.9)
7%-12.9% 3224 (33) 1670 (35) 3468 (32) 2.3 (0.6 to 3.9) −0.7 (−1.9 to 0.6)
<7% 2540 (26) 1032 (22) 2158 (20) −4.2 (−5.7 to −2.8) −5.9 (−7.0 to −4.7)
Unknown 102 (1) 58 (1) 124 (1) 0.2 (−0.2 to 0.6) 0.1 (−0.2 to 0.4)
Income, $b
<38,000 1575 (16) 847 (18) 2109 (20) 1.8 (0.4 to 3.1) 3.6 (2.5 to 4.6)
38 000-47 999 2292 (23) 1183 (25) 2758 (26) 1.5 (0 to 3.0) 2.3 (1.1 to 3.4)
48 000-62 999 2678 (27) 1288 (27) 2834 (26) −0.2 (−1.8 to 1.3) −1.0 (−2.2 to 0.2)
≥63 000 3114 (32) 1359 (29) 2886 (27) −3.2 (−4.8 to −1.6) −5.0 (−6.2 to −3.7)
Unknown 106 (1) 58 (1) 129 (1) 0.1 (−0.2 to 0.5) 0.1 (−0.2 to 0.4)
Insurance
Medicare 2534 (26) 1426 (30) 3478 (32) 4.2 (2.6 to 5.7) 6.5 (5.3 to 7.7)
Medicaid 754 (8) 491 (10) 1448 (14) 2.6 (1.6 to 3.7) 5.8 (5.0 to 6.6)
Private/managed care/other government 5861 (60) 2510 (53) 4952 (46) −7.0 (−8.7 to −5.3) −13.8 (−15.2 to −12.5)
None 456 (5) 257 (5) 680 (6) 0.8 (−0 to 1.5) 1.7 (1.1 to 2.3)
Unknown 160 (2) 51 (1) 158 (1) −0.6 (−0.9 to −0.2) −0.2 (−0.5 to 0.2)
Charlson/Deyo score
0 7976 (82) 3744 (79) 8246 (77) −2.6 (−4.0 to −1.2) −4.7 (−5.8 to −3.6)
1 1471 (15) 783 (17) 1946 (18) 1.5 (0.2 to 2.7) 3.1 (2.1 to 4.1)
≥2 318 (3) 208 (4) 524 (5) 1.1 (0.5 to 1.8) 1.6 (1.1 to 2.2)
Disease site
Tonsil 4353 (45) 1344 (28) 2383 (22) −16.2 (−17.8 to −14.6) −22.3 (−23.6 to −21.1)
Nontonsil oropharynx 1202 (12) 527 (11) 1094 (10) −1.2 (−2.3 to −0.1) −2.1 (−3.0 to −1.2)
Oral cavity 2635 (27) 1895 (40) 4769 (45) 13.0 (11.4 to 14.7) 17.5 (16.2 to 18.8)
Larynx 1360 (14) 825 (17) 2034 (19) 3.5 (2.2 to 4.8) 5.1 (4.0 to 6.1)
Hypopharynx 215 (2) 144 (3) 436 (4) 0.8 (0.3 to 1.4) 1.9 (1.4 to 2.3)
Stage
III 2469 (25) 1086 (23) 2240 (21) −2.3 (−3.8 to −0.9) −4.4 (−5.5 to −3.2)
IV 7296 (75) 3649 (77) 8476 (79) 2.3 (0.9 to 3.8) 4.4 (3.2 to 5.5)
Extracapsular extension
No 4563 (47) 2056 (43) 4393 (41) −3.3 (−5.0 to −1.6) −5.7 (−7.1 to −4.4)
Yes 2513 (26) 1370 (29) 2955 (28) 3.2 (1.6 to 4.8) 1.8 (0.6 to 3.1)
Node negative 1383 (14) 893 (19) 2396 (22) 4.7 (3.4 to 6.0) 8.2 (7.1 to 9.2)
Unknown 1306 (13) 416 (9) 972 (9) −4.6 (−5.6 to −3.5) −4.3 (−5.2 to −3.4)
Margin status
Negative 6349 (65) 3438 (73) 7886 (74) 7.6 (6.0 to 9.2) 8.6 (7.3 to 9.8)
Positive 1019 (10) 423 (9) 899 (8) −1.5 (−2.5 to −0.5) −2.0 (−2.8 to −1.2)
Unknown 2397 (25) 874 (18) 1931 (18) −6.1 (−7.5 to −4.7) −6.5 (−7.6 to −5.4)
Lymphovascular invasion
Absent 2578 (26) 1336 (28) 3002 (28) 1.8 (0.3 to 3.4) 1.6 (0.4 to 2.8)
Present 1119 (11) 650 (14) 1486 (14) 2.3 (1.1 to 3.4) 2.4 (1.5 to 2.7)
Unknown 6068 (62) 2749 (58) 6228 (58) −4.1 (−5.8 to −2.4) −4.0 (−5.4 to −2.7)
Year of diagnosis
2004-2006 2377 (24) 1089 (23) 2378 (22) −1.3 (−2.8 to 0.1) −2.2 (−3.3 to −1.0)
2007-2009 2505 (26) 1254 (26) 2870 (27) 0.8 (−0.7 to 2.4) 1.1 (−0.1 to 2.3)
2010-2013 4883 (50) 2392 (51) 5468 (51) 0.5 (−1.2 to 2.2) 1.0 (−0.3 to 2.4)
TD-S, d
<68 9221 (94) 4368 (92) 9661 (90) −2.2 (−3.1 to −1.3) −4.3 (−5.0 to −3.5)
≥68 544 (6) 367 (8) 1055 (10) 2.2 (1.3 to 3.1) 4.3 (3.5 to 5.0)
Treating facilities
Academic (surgery and radiation) 3509 (36) 1810 (38) 3932 (37) 2.3 (0.6 to 4.0) 0.8 (−0.6 to 2.1)
Academic (surgery) 877 (9) 640 (14) 1602 (15) 4.5 (3.4 to 5.7) 6.0 (5.1 to 6.9)
Comprehensive community (surgery and radiation) 2730 (28) 1159 (24) 2594 (24) −3.5 (−5.0 to −2.0) −3.8 (−5.0 to −2.5)
Comprehensive community (surgery) 655 (7) 256 (5) 581 (5) −1.3 (−2.1 to −0.5) −1.3 (−1.9 to −0.6)
Community (surgery and radiation) 539 (6) 244 (5) 551 (5) −0.4 (−1.1 to 0.4) −0.4 (−1.0 to 0.2)
Community (surgery) 198 (2) 70 (1) 151 (1) −0.5 (−1.0 to −0.1) −0.6 (−1.0 to −0.3)
Other (surgery and radiation) 989 (10) 423 (9) 995 (9) −1.2 (−2.2 to −0.2) −0.8 (−1.7 to 0)
Other (surgery) 268 (3) 133 (3) 310 (3) 0.1 (−0.5 to 0.6) 0.1 (−0.3 to 0.6)
Distance to facility, miles
≤10 4275 (44) 1942 (41) 4585 (43) −2.8 (−4.5 to −1.1) −1.0 (−2.4 to 0.4)
11-20 2119 (22) 1008 (21) 2224 (21) −0.4 (−1.8 to 1.0) −0.9 (−2.1 to 0.2)
21-50 1943 (20) 1019 (22) 2232 (21) 1.6 (0.2 to 3.0) 0.9 (−0.2 to 2.0)
51-100 820 (8) 466 (10) 1036 (10) 1.4 (0.4 to 2.5) 1.3 (0.5 to 2.1)
>100 608 (6) 300 (6) 639 (6) 0.1 (−0.7 to 1.0) −0.3 (−0.9 to 0.4)
Hospital length of stay, d
0-7 6420 (66) 2506 (53) 4968 (46) −12.8 (−14.5 to −11.1) −19.4 (−20.7 to −18.1)
>7 1250 (13) 1074 (23) 3084 (29) 9.9 (8.5 to 11.2) 16.0 (14.9 to 17.1)
Unknown 2095 (21) 1155 (24) 2664 (25) 2.9 (1.5 to 4.4) 3.4 (2.3 to 4.6)
30-Day unplanned readmission status
No 9067 (93) 4362 (92) 9692 (90) −0.7 (−1.7 to 0.2) −2.4 (−3.2 to −1.7)
Yes 262 (3) 140 (3) 414 (4) 0.3 (−0.3 to 0.9) 1.2 (0.7 to 1.7)
Unknown 436 (4) 233 (5) 610 (6) 0.5 (−0.3 to 1.2) 1.2 (0.6 to 1.8)
Radiation dose, Gy
45.00-49.99 87 (1) 56 (1) 165 (2) 0.3 (−0.1 to 0.7) 0.6 (0.4 to 0.9)
50.00-53.99 321 (3) 171 (4) 392 (4) 0.3 (−0.3 to 1.0) 0.4 (−0.1 to 0.9)
54.00-59.99 687 (7) 427 (9) 1047 (10) 2.0 (1.0 to 2.9) 2.7 (2.0 to 3.5)
60.00-65.99 3746 (38) 2193 (46) 4893 (46) 8.0 (6.2 to 9.7) 7.3 (6.0 to 8.6)
66.00-69.99 2570 (26) 1262 (27) 2768 (26) 0.3 (−1.2 to 1.9) −0.5 (−1.7 to 0.7)
70.00-76.00 2354 (24) 626 (13) 1451 (14) −10.9 (−12.2 to −9.6) −10.6 (−11.6 to −9.5)
Radiation modality
3-D Conformal 242 (2) 108 (2) 295 (3) −0.2 (−0.7 to 0.3) 0.3 (−0.2 to 0.7)
IMRT 5634 (58) 2751 (58) 6104 (57) 0.4 (−1.3 to 2.1) −0.7 (−2.1 to 0.6)
Unknown 3889 (40) 1876 (40) 4317 (40) −0.2 (−1.9 to 1.5) 0.5 (−0.9 to 1.8)
Chemotherapy
Not given 3314 (34) 1956 (41) 4618 (43) 7.4 (5.7 to 9.1) 9.2 (7.8 to 10.5)
Adjuvant 6148 (63) 2630 (56) 5679 (53) −7.4 (−9.1 to −5.7) −10.0 (−11.3 to −8.6)
Neoadjuvant 102 (1) 39 (1) 124 (1) −0.2 (−0.5 to 0.1) 0.1 (−0.2 to 0.4)
Adjuvant and neoadjuvant 51 (1) 37 (1) 79 (1) 0.3 (0 to 0.5) 0.2 (0 to 0.4)
Unknown 150 (2) 73 (2) 216 (2) 0 (−0.4 to 0.4) 0.5 (0.1 to 0.8)

Abbreviations: 3-D, 3-dimensional; IMRT, intensity modulated radiation therapy; TD-S, time from diagnosis to surgery.

a

Education indicates the percent of people with no high school degree in the patient’s zip code of residence.

b

Income indicates the median household income in the patient’s zip code of residence.